Se connecter

Bibliographies thématiques / Primary percutaneous coronary intervention (PCI) / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Primary percutaneous coronary intervention (PCI).

Articles de revues sur le sujet « Primary percutaneous coronary intervention (PCI) »

Auteur : Grafiati

Publié le 7 juin 2025

Mis à jour le 2 août 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Primary percutaneous coronary intervention (PCI) ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

H, Emara. "Coronary No-Reflow after Primary Percutaneous Coronary Intervention." Open Access Journal of Cardiology 8, no. 1 (2024): 1–3. http://dx.doi.org/10.23880/oajc-16000205.

Texte intégral

Résumé :

Coronary no-reflow is a significant complication following primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction. This phenomenon involves inadequate myocardial perfusion despite successful vessel recanalization, attributed to factors such as microvascular injury, inflammation, thrombus embolization, and vasospasm. Effective management strategies include pharmacological agents, mechanical interventions, and optimized antithrombotic therapy. Prompt diagnosis and treatment are essential to enhance patient outcomes and reduce adverse effects associated with

Styles APA, Harvard, Vancouver, ISO, etc.

2

Emara, Haytham. "In-Situ Thrombosis Post Primary Percutaneous Coronary Intervention and Possible Management." Open Access Journal of Cardiology 8, no. 1 (2024): 1–2. http://dx.doi.org/10.23880/oajc-16000200.

Texte intégral

Résumé :

Background: Several intracoronary agents have been used by interventional cardiologists, in context of PCI iatrogenic thrombosis. Recently the use of low-dose fibrinolysis at the time of the primary PCI has gained popularity as a new strategy to improve post-procedural coronary flow. Conclusion: Using low-dose fibrinolytic therapy at the time of primary PCI might play a vital role in minimizing the risk of microvascular thrombus.

Styles APA, Harvard, Vancouver, ISO, etc.

3

Maryam, Mehrpooya, Sadeghian Mohammad, and Shayan Mirshafiee. "Entrapment of Unraveled Coronary Guidewire in Right Coronary Artery during Primary Percutaneous Coronary Intervention." Research in Cardiovascular Medicine 14, no. 1 (2025): 47–49. https://doi.org/10.4103/rcm.rcm_77_24.

Texte intégral

Résumé :

Abstract Along with the increasing number of percutaneous coronary interventions (PCIs), rare complications occur more frequently than before. In this case, we represent a patient with inferior ST-elevation myocardial infarction whom became complicated with entrapment of unraveled coronary guidewire during primary PCI and our percutaneous intervention despite previously recommended surgical management in the same situation.

Styles APA, Harvard, Vancouver, ISO, etc.

4

Datta, Goutam. "Intracoronary Thrombolysis in no Flow after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction." Clinical Cardiology and Cardiovascular Interventions 3, no. 13 (2020): 01–05. http://dx.doi.org/10.31579/2641-0419/114.

Texte intégral

Résumé :

Introduction: Mechanical revascularization of the infarct-related artery (IRA) is the most effective treatment modality in ST-segment elevation myocardial infarction (STEMI).No-reflow occurs in ∼8.8-10% of cases of primary percutaneous coronary intervention(PCI) in STEMI patients. Intracoronary tenectaplase was used when there was huge thrombus causing no flow in coronary artery following primary PCI in STEMI patients. Methods: Five hundred and eighty primary PCI patients were studied over a period of two years i.e. January 2016 to December 2017. Drug eluting stents were used in all cases. Maj

Styles APA, Harvard, Vancouver, ISO, etc.

5

Dehmer, Gregory J. "Percutaneous Coronary Intervention without On-site Surgical Back-up." Interventional Cardiology Review 4, no. 1 (2009): 12. http://dx.doi.org/10.15420/icr.2009.4.1.12.

Texte intégral

Résumé :

Although accepted in several countries, in the US the performance of percutaneous coronary intervention (PCI) without on-site surgical back-up remains controversial. The current US guidelines do not endorse elective PCI in facilities without on-site surgical back-up, but acknowledge that primary PCI for ST-segment elevation myocardial infarction (STEMI) is acceptable under carefully regulated and monitored circumstances. In the US, survey data indicate that either primary PCI alone or primary and elective PCI without on-site surgery is currently being performed in all but seven states, and the

Styles APA, Harvard, Vancouver, ISO, etc.

6

Saji, Agnel, Agra Shyni Raj, and George Mathew Neeraakal. "Clinical End Result in Indian Patients Undergoing Primary Percutaneous Coronary Intervention in Institution without Onsite Surgical Facilities." Journal of Evolution of Medical and Dental Sciences 11, no. 1 (2022): 157–62. http://dx.doi.org/10.14260/jemds/2022/30.

Texte intégral

Résumé :

BACKGROUND Primary percutaneous coronary intervention is one of the treatment options for STelevation myocardial infarction and is relatively safer and superior to thrombolytic therapy. The decrease in time to reperfusion leads to decreased infarct size and hence incidence of major adverse cardiac events (MACE). This knowledge has led to the concept of off-site percutaneous coronary intervention centres (without surgical backup). However, performing primary percutaneous coronary intervention at centres without surgical backup has been controversial. Controversy arises regarding the safety and

Styles APA, Harvard, Vancouver, ISO, etc.

7

Khan, Muhammad Ijaz, Muhammad Umar Farooq, Hamid Iqbal, Syed Imran Ahmed Kazmi, Iffat Aqeel, and Bakht Umar Khan. "Effect of No-Reflow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction on Six-Month Mortality." Pakistan Journal of Medical and Health Sciences 17, no. 2 (2023): 796–98. http://dx.doi.org/10.53350/pjmhs2023172796.

Texte intégral

Résumé :

Background: No-reflow is a serious complication that can occur during primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). No-reflow is a frequent event during percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI), and it may affect cardiac prognosis. Objectives: The main objective of the study is to find the effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Methods: This study was conducted at Ayub Teaching Hospital Abbottabad over a period of six months (1st

Styles APA, Harvard, Vancouver, ISO, etc.

8

Almelor, Lorraine Grace B., Cheryl K. Fomaneg, Aleano L. Dayag, and Paul Ferdinand M. Reganit. "Complete Percutaneous Coronary Intervention versus Culprit Only Percutaneous Coronary Intervention for Acute ST Elevation Myocardial Infarction with Multivessel Coronary Artery Disease: A Meta-analysis." Philippine Journal of Cardiology 43, no. 1 (2015): 48–55. http://dx.doi.org/10.69944/pjc.303beab87c.

Texte intégral

Résumé :

BACKGROUND: Current guidelines recommend that primary percutaneous coronary intervention (PCI) in hemodynamically stable acute ST-elevation myocardial infarction (STEMI) patients should be limited to the culprit vessel despite significant stenosis in nonculprit coronary arteries. Recent studies and meta-analyses provide conflicting data. OBJECTIVES: This review compared the efficacy of culprit (infarctrelated artery only) primary PCI versus complete (infarctrelated artery and at least one other artery with significant stenosis) primary PCI in acute STEMI patients with multivessel coronary arte

Styles APA, Harvard, Vancouver, ISO, etc.

9

Hakim, Radwan, Eric Revue, Christophe Saint Etienne, et al. "Does helicopter transport delay prehospital transfer for STEMI patients in rural areas? Findings from the CRAC France PCI registry." European Heart Journal: Acute Cardiovascular Care 9, no. 8 (2019): 958–65. http://dx.doi.org/10.1177/2048872619848976.

Texte intégral

Résumé :

Aims: The aim of this study was to analyse delays in emergency medical system transfer of ST-segment elevation myocardial infarction (STEMI) patients to percutaneous coronary intervention (PCI) centres according to transport modality in a rural French region. Methods and results: Data from the prospective multicentre CRAC / France PCI registry were analysed for 1911 STEMI patients: 410 transferred by helicopter and 1501 by ground transport. The primary endpoint was the percentage of transfers with first medical contact to primary percutaneous coronary intervention within the 90 minutes recomme

Styles APA, Harvard, Vancouver, ISO, etc.

10

Rymer, Jennifer A., Zachary K. Wegermann, Tracy Y. Wang, et al. "Ventricular Arrhythmias After Primary Percutaneous Coronary Intervention for STEMI." JAMA Network Open 7, no. 5 (2024): e2410288. http://dx.doi.org/10.1001/jamanetworkopen.2024.10288.

Texte intégral

Résumé :

ImportanceCurrently, mortality risk for patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with an uncomplicated postprocedure course is low. Less is known regarding the risk of in-hospital ventricular tachycardia (VT) and ventricular fibrillation (VF).ObjectiveTo evaluate the risk of late VT and VF after primary PCI for STEMI.Design, Setting, and ParticipantsThis cohort study included adults aged 18 years or older with STEMI treated with primary PCI between January 1, 2015, and December 31, 2018, identified in the US

Styles APA, Harvard, Vancouver, ISO, etc.

11

ASLAM, K., E. IQBAL, MS KHAN, FR KHAN, and W. SAJJAD. "ASSESSMENT OF LONG-TERM OUTCOMES OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CHRONIC TOTAL OCCLUSIONS." Biological and Clinical Sciences Research Journal 2024, no. 1 (2024): 729. http://dx.doi.org/10.54112/bcsrj.v2024i1.729.

Texte intégral

Résumé :

A minimal surgical procedure called ‘PCI’ (percutaneous coronary intervention) is performed to treat those who have diseases of the coronary arteries. A period of more than three months of entire blockage of a coronary artery results in a ‘CTO’ (chronic total occlusions). The primary goal of the research is to determine the performance of patients who have ‘PCI’ (percutaneous coronary intervention) for chronic total occlusions (CTO). The study was conducted at Lady Reading Hospital MTI from March 2022 to December 2022. The research included 400 individuals with ‘percutaneous coronary intervent

Styles APA, Harvard, Vancouver, ISO, etc.

12

Wright, S., and R. Jayasinghe. "Primary Percutaneous Coronary Intervention (PCI) Outcomes in the Elderly." Heart, Lung and Circulation 19 (January 2010): S148. http://dx.doi.org/10.1016/j.hlc.2010.06.1018.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Scudiero, Fernando, Iacopo Muraca, Angela Migliorini, et al. "Outcomes of Left Main Revascularization after Percutaneous Intervention or Bypass Surgery." Journal of Interventional Cardiology 2022 (April 12, 2022): 1–9. http://dx.doi.org/10.1155/2022/6496777.

Texte intégral

Résumé :

Background. This study is aimed at comparing the clinical outcomes of unprotected left main coronary artery disease (ULMCAD) treatment with contemporary percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in a “real-world” population. Methods and Results. Overall, 558 consecutive patients with ULMCAD (mean age 71 ± 9 years, male gender 81%) undergoing PCI or CABG were compared. The primary endpoint was the composite of death, nonfatal myocardial infarction, or stroke. Diabetes was present in 29% and acute coronary syndrome in 56%; mean EuroSCORE was 11 ± 8. High

Styles APA, Harvard, Vancouver, ISO, etc.

14

White, Kevin, Judy Currey, and Julie Considine. "Assessment Framework for Recognizing Clinical Deterioration in Patients With ACS Undergoing PCI." Critical Care Nurse 41, no. 4 (2021): 18–28. http://dx.doi.org/10.4037/ccn2021904.

Texte intégral

Résumé :

Topic Patients with acute coronary syndrome undergoing primary percutaneous coronary intervention are at risk of clinical deterioration that results in similar general signs and symptoms regardless of its cause. However, specific causes and forms of clinical deterioration are associated with key differences in assessment findings. Focused clinical assessments using a modified primary survey enable nurses to rapidly identify the cause and form of clinical deterioration, facilitating targeted treatment. Clinical Relevance Clinical deterioration during percutaneous coronary intervention is associ

Styles APA, Harvard, Vancouver, ISO, etc.

15

Widianingsih, Heny, and Sahrudi Sahrudi. "Efektivitas Tindakan Primary Percutaneous Coronary Intervention Pada Pasien Stemi Onset Kurang Dari 6 Jam." Malahayati Nursing Journal 4, no. 3 (2022): 733–45. http://dx.doi.org/10.33024/mnj.v4i3.6086.

Texte intégral

Résumé :

ABSTRACT In ST-elevation myocardial infarction patients, there is a sudden decrease in coronary blood flow due to thrombus occlusion in a preexisting atherosclerotic plaque. Efforts to reduce the death rate from coronary heart disease continue to be developed, starting from reducing risk factors, medical therapy to heart surgery. One of the most commonly used methods is cardiac catheterization, including Percutaneous Coronary Intervention (PCI). Purpose To determine the effectiveness of primary PCI in STEMI patients with onset less than 6 hours at Primaya Hospital, West Bekasi in 2021. The des

Styles APA, Harvard, Vancouver, ISO, etc.

16

Farhat Ullah Khan, Muhammad Idrees Khan, Samiullah, Muhammad Asad Khan, Naeem Khan, and Muzdalfa Parvez. "Clinical Significance of Microvascular Obstruction Following Primary Percutaneous Coronary Intervention." Journal of Islamabad Medical & Dental College 14, no. 1 (2025): 69–74. https://doi.org/10.35787/jimdc.v14i1.1363.

Texte intégral

Résumé :

Objective: To evaluate the clinical significance of Microvascular obstruction following primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) and to assess its impact on myocardial recovery and long-term outcomes. Methodology: This retrospective study was conducted at Department of Cardiology, Hayatabad Medical Complex, Peshawar, from January 2018 to December 2018. A total of 250 STEMI patients undergoing primary PCI were enrolled. Data on demographics, clinical presentation, angiographic characteristics, and procedural details wer

Styles APA, Harvard, Vancouver, ISO, etc.

17

Toyota, Toshiaki, Takeshi Morimoto, Hiroki Shiomi, et al. "Single-session versus staged procedures for elective multivessel percutaneous coronary intervention." Heart 104, no. 11 (2017): 936–44. http://dx.doi.org/10.1136/heartjnl-2017-312117.

Texte intégral

Résumé :

ObjectivesTo clarify the effect of single-session multivessel percutaneous coronary intervention (PCI) strategy relative to the staged multivessel strategy on clinical outcomes in patients with stable coronary artery disease (CAD) or non-ST-elevation acute coronary syndrome.MethodsIn the Coronary REvascularisation Demonstrating Outcome Study in Kyoto PCI/coronary artery bypass grafting registry cohort-2, there were 2018 patients who underwent elective multivessel PCI. Primary outcome measure was composite of all-cause death, myocardial infarction and stroke at 5-year follow-up.ResultsSingle-se

Styles APA, Harvard, Vancouver, ISO, etc.

18

Esa, Kerols Safwat Ayob, Ibtsam Khairat Abdelhayi, Yasser El Barbary, and Mai Mohamed Salama. "Predictors of Bleeding after Percutaneous Coronary Intervention." Cardiology and Angiology: An International Journal 12, no. 4 (2023): 154–61. http://dx.doi.org/10.9734/ca/2023/v12i4354.

Texte intégral

Résumé :

Background: Acute coronary syndrome patient outcomes have been improved using early invasive techniques. The aim of this study was to investigate the incidence, location, and severity of bleeding in PCI-treated cases to identify patient risk profiles and increased bleeding occurrences. Methods: This prospective observational study evaluated percutaneous coronary angiography in 80 patients with hypertension and diabetes mellitus who planned to undergo primary or elective PCI. The cases were separated into 2 groups; those who reported bleeding (n=11) and those who did not (n=69). All patie

Styles APA, Harvard, Vancouver, ISO, etc.

19

Tomandao, Kathy Lou B. "Outcomes of Intravascular Ultrasound Guided-Percutaneous Coronary Intervention versus Conventional Percutaneous Coronary Intervention: A Meta-analysis of Randomized Controlled Trials." Philippine Journal of Cardiology 41, no. 2 (2013): 98–102. http://dx.doi.org/10.69944/pjc.fa16614577.

Texte intégral

Résumé :

BACKGROUND: Coronary angiography has been the standard test in evaluating coronary artery disease. However, this procedure has its limitations in estimating disease severity. Intravascular ultrasound (IVUS) promises to be a more sensitive tool for correct assessment of true lumen dimensions and architecture, as well as atherosclerotic plaque burden and vessel wall abnormalities. The use of IVUS during percutaneous coronary intervention (PCI) may therefore optimize the results of PCI, particularly of stent implantation. In addition, IVUS provides the operator with better information on real ves

Styles APA, Harvard, Vancouver, ISO, etc.

20

Khan, Asad, Abdul Latif, Samiullah ., Muhammad Shahab Uddin Khalil, Muzdalfa Parvez, and Zarmina Ikram. "Predictors of Suboptimal Coronary Blood Flow during Primary Percutaneous Intervention." Pakistan Journal of Medical and Health Sciences 16, no. 10 (2022): 908–10. http://dx.doi.org/10.53350/pjmhs221610908.

Texte intégral

Résumé :

Background and aim: Suboptimal coronary blood flow following first percutaneous coronary intervention (PCI) is a multivariate phenomenon with several causes. Despite substantial research, recognized modifiable risk factors and an effective management plan are lacking. The present study intended to determine the several causes of suboptimal coronary blood flow during primary percutaneous intervention. Patients and Method: A retrospective study was carried out on 486 STEMI patients in the Interventional Cardiology Department, MTI-Hayatabad Medical Complex, Peshawar from June 2021 to May 2022. Pa

Styles APA, Harvard, Vancouver, ISO, etc.

21

Kiani, Sadaf Shabbir, Asif Nadeem, Azhar Ali Chauhdry, et al. "Treatment of Refractory No-Reflow in Cardiac Catheterization Laboratory; Role of Intracoronary Verapamil (A Case Report)." Pakistan Armed Forces Medical Journal 72, SUPPL-3 (2022): S543–46. http://dx.doi.org/10.51253/pafmj.v72isuppl-3.9521.

Texte intégral

Résumé :

The no reflow phenomenon is a feared complication in Percutaneous Coronary Intervention (PCI) procedures including elective as well as primary PCI (Percutaneous Coronary Intervention), and results in worse prognosis. A number of etiological factors are involved in pathogenesis of no reflow phenomenon. These include distal athero embolization, ischemic and reperfusion injury, microvascular spasm and endothelial dysfunction. The treatment of no reflow depends on underlying mechanism and includes pharmacological as well as non-pharmacological interventions. Pharmacological agents include vasodila

Styles APA, Harvard, Vancouver, ISO, etc.

22

Ahmed, Farhana, Afzalur Rahman, Mohammad Arifur Rahman, et al. "Predictors of Short Term Outcomes of Primary Percutaneous Coronary Intervention." Bangladesh Heart Journal 33, no. 2 (2018): 112–20. http://dx.doi.org/10.3329/bhj.v33i2.39307.

Texte intégral

Résumé :

Background: Acute myocardial infarction (AMI) is one of the leading causes of death and disability all over the world. Primary percutaneous coronary intervention (PCI) is the treatment of choice for patients with acute ST segment elevation myocardial infarction (STEMI). Primary PCI is being increasingly done in our country also. But the factor influencing the outcome of primary PCI in our setting are mostly unknown. The present study was conducted to investigate factors that influencing the short term outcomes of primary PCI. Materials and methods: This prospective observational study wa

Styles APA, Harvard, Vancouver, ISO, etc.

23

Jalalian, Rozita, Samad Golshani, Hossein Farsavian, Mahsa Vatani, and Ali Asghar Farsavian. "Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients." Journal of Medicine and Life 14, no. 3 (2021): 376–82. http://dx.doi.org/10.25122/jml-2021-0035.

Texte intégral

Résumé :

Early and complete restoration of blood flow in closed coronary arteries is the main goal in treating patients with myocardial infarction. Primary angioplasty is not always successful in establishing myocardial blood flow. Although the strategy of adding eptifibatide leads to better blood flow, its value as part of a routine strategy is questionable. Therefore, this study was performed to evaluate the efficacy of intravenous eptifibatide in primary percutaneous coronary intervention (PCI) patients. This clinical, randomized, double-blind trial was performed on patients aged 20-80 years undergo

Styles APA, Harvard, Vancouver, ISO, etc.

24

Emara, Haytham. "Role of Sodium Nitroprusside in Primary PCI." Open Access Journal of Cardiology 8, no. 1 (2024): 1–3. http://dx.doi.org/10.23880/oajc-16000207.

Texte intégral

Résumé :

Sodium nitroprusside (SNP), a potent vasodilator with a rapid onset and short duration of action, has traditionally been used to manage acute hypertension in emergency settings. Its mechanism of action involves the release of nitric oxide (NO), leading to vascular smooth muscle relaxation. This article reviews the evolving role of SNP in primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). While SNP has demonstrated benefits in improving coronary flow and left ventricular function, concerns about potential ischemic injury through “coronary steal” effect neces

Styles APA, Harvard, Vancouver, ISO, etc.

25

Jawad, Muhammad, Nauman Ali, and Adeela Shahzadi. "Frequency of Coronary Artery Anomalies Among Adult Patients Undergoing Primary Percutaneous Coronary Intervention." Biological and Clinical Sciences Research Journal 6, no. 5 (2025): 46–49. https://doi.org/10.54112/bcsrj.v6i5.1703.

Texte intégral

Résumé :

Coronary artery anomalies (CAAs) are congenital variations in coronary anatomy that may be encountered during primary percutaneous coronary intervention (PCI). Early recognition is critical to avoid procedural complications, especially during emergent interventions. Objective: To determine the frequency and types of CAAs in adult patients undergoing primary PCI in a tertiary care hospital in Pakistan. Methods: This descriptive cross-sectional study was conducted over six months at the Department of Cardiology, Bahawal Victoria Hospital (BVH), Bahawalpur, from 3rd October 2024 to 3rd April 2025

Styles APA, Harvard, Vancouver, ISO, etc.

26

Cahoon, William D., and Michael A. Crouch. "Preprocedural Statin Therapy in Percutaneous Coronary Intervention." Annals of Pharmacotherapy 41, no. 10 (2007): 1687–93. http://dx.doi.org/10.1345/aph.1k248.

Texte intégral

Résumé :

Objective: To review the published literature regarding the effectiveness or preprocedural statin therapy for the prevention of cardiac events after percutaneous coronary intervention (PCI). Data Sources: Searches of MEDLINE (1966–May 2007) and Cochrane Database (1993–May 2007) were conducted using the search terms statins, HMG-CoA reductase inhibitors, percutaneous coronary intervention, and myocardial necrosis. Limits included articles written in English with human subjects. Additional data were identified through bibliographic reviews. Study Selection and Data Extraction: All English-langua

Styles APA, Harvard, Vancouver, ISO, etc.

27

Platon, Pavel, and Carmen Ginghina. "Clinical and angiographic predictors in primary percutaneous intervention." Romanian Journal of Cardiology 30, no. 2 (2020): 230–35. http://dx.doi.org/10.47803/rjc.2020.30.2.230.

Texte intégral

Résumé :

Percutaneous coronary intervention (PCI) in patients presenting with acute myocardial infarction with ST segment elevation (STEMI) is the standard treatment according to the current European Society of Cardiology Guidelines. Certain aspects of therapy remain under debate, as periodic changes in the guidelines are enabled by new and thorough research. Objectives – We aimed to evaluate clinical and angiographic prognostic factors in patients presenting with acute STEMI treated with primary PCI. Methods – Demographical, clinical and procedural parameters were retrospectively analysed for 303 cons

Styles APA, Harvard, Vancouver, ISO, etc.

28

Khan, Nasir, Habib Ul Haq, Sarfraz Hussain Sahito, Syed Zain Raza Naqvi, Waqqas Ishaq, and Shahzad Majeed Bhatti. "Using a Transradial Method, The Results of Primary Percutaneous Coronary Intervention at a Tertiary Care Cardiac Centre." Pakistan Journal of Medical and Health Sciences 17, no. 3 (2023): 732–35. http://dx.doi.org/10.53350/pjmhs2023173732.

Texte intégral

Résumé :

Objective: The purpose of this study is to investigate the in-hospital outcomes of primary percutaneous coronary intervention (PCI) performed using a transradial technique in a cardiac centre that provides tertiary care. Study Design: Descriptive/ observational study Place and Duration: Department of cardiology, Peshawar Institute of Cardiology, Hayatabad phase 5 Peshawar, KPK in the duration from April, 2022 to September, 2022. Methods: 104 patients were included in the trial; all had ST-segment elevation myocardial infarction and had presented within 12 hours of symptom onset without a histo

Styles APA, Harvard, Vancouver, ISO, etc.

29

Islam, AHM Waliul, AQM Reza, Shams Munwar, and Shahabuddin Talukder. "Revascularization Failure: Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting." Cardiovascular Journal 15, no. 1 (2022): 81–85. http://dx.doi.org/10.3329/cardio.v15i1.61915.

Texte intégral

Résumé :

Coronary artery disease (CAD) is one of the leading causes of mortality and morbidity in our Bangladeshi patient population. Percutaneous coronary intervention (PCI) or Coronary artery bypass grafting (CABG) are the gold standard of revascularization to treat these group of patients. Both treatment modalities may contribute to both short term and long-term excellent benefit with the relief of symptoms and improves quality of life. Beside the availability of modern techniques along with 3rd generation Drug eluting stents (DES) for PCI and uses of arterial conduit in bypass surgery, in long-term

Styles APA, Harvard, Vancouver, ISO, etc.

30

Fakhriev, J.A., and F.D. Mamatkulova. "ATRIAL FIBRILLATION AFTER PERCUTANEOUS CORONARY INTERVENTION." Annali d'Italia 39 (January 25, 2023): 44–46. https://doi.org/10.5281/zenodo.7568846.

Texte intégral

Résumé :

Atrial fibrillation is an important arrhythmia with a soaring popularity included in population. Atrial fibrillation is not uncommon in the setting of coronary artery disease, including myocardial infarction and acute coronary syndromes. Percutaneous coronary interventions have remarkably enhanced results of patients with acute myocardial infarction and acute coronary syndromes. However, the atrial fibrillation was reported to occur in patients with myocardial infarction and acute coronary syndromes undergoing percutaneous coronary intervention. New onset atrial fibrillation after PCI for myoc

Styles APA, Harvard, Vancouver, ISO, etc.

31

Safiuddin, Mohammad, Ahmed Saiful Bari, Md Sharifur Rashid, Md Hasibul Hasan, Md Nazmul Hasan, and Lohani Md Tajul Islam. "Successful Primary PCI in Left Anterior Descending Artery Managing Acute Myocardial Infarction." University Heart Journal 10, no. 1 (2015): 45–46. http://dx.doi.org/10.3329/uhj.v10i1.24604.

Texte intégral

Résumé :

Coronary reperfusion with primary percutaneous coronary intervention (PPCI) or fibrinolytic therapy improves outcomes in patients with acute ST elevation myocardial infarction (STEMI) or an acute myocardial infarction (AMI) with a new or presumably new left bundle branch block or a true posterior MI. If performed in a timely fashion, PPCI is the reperfusion therapy of choice compared to fibrinolysis because it achieves a higher rate of TIMI 3 flow. Here we describe a case of acute ST elevated anterior myocardial infarction managed with primary percutaneous coronary intervention with the insert

Styles APA, Harvard, Vancouver, ISO, etc.

32

KHAN, AS, F. ULLAH, TI KHAN, MQU MURSALIN, S. AKBER, and Y. HAYAT. "STUDY OF SUCCESS RATE AND COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION IN CTO INTERVENTION." Biological and Clinical Sciences Research Journal 2024, no. 1 (2024): 1201. http://dx.doi.org/10.54112/bcsrj.v2024i1.1201.

Texte intégral

Résumé :

Chronic total occlusion (CTO) is one of the most complex and challenging forms of coronary artery disease, characterized by the complete obstruction of a coronary artery for more than three months. Objective: The primary aim of this study is to assess the success rate of PCI in patients with CTO and to evaluate the frequency and types of complications associated with the procedure. Methods: Patients included in the study were diagnosed with CTO using coronary angiography. The PCI procedures were carried out using standard techniques, and the primary endpoints were technical success and clinica

Styles APA, Harvard, Vancouver, ISO, etc.

33

Sugiharto, Firman, Aan Nuraeni, Yanny Trisyani, Azalia Melati Putri, and Nuraulia Aghnia Armansyah. "Nursing interventions for improving quality of life among patients with coronary heart disease after percutaneous coronary intervention: A scoping review." Jurnal Keperawatan Padjadjaran 12, no. 1 (2024): 56–67. http://dx.doi.org/10.24198/jkp.v12i1.2294.

Texte intégral

Résumé :

Background: Percutaneous coronary intervention (PCI) aims to improve the quality of life (QoL) for coronary heart disease (CHD) patients, but many patients still have poor QoL. The impact of poor QoL causes long-lasting feelings of frustration, anxiety, fear, and worry that make a person give up or lose enthusiasm for the future. Objective: This study aimed to describe nursing interventions to improve the QoL of CHD patients after PCI. Methods: This research used the scoping review method by including all full-text primary studies written in English and published between 2013 to 2023 from thre

Styles APA, Harvard, Vancouver, ISO, etc.

34

Izkhakov, Elena, Zach Rozenbaum, Gilad Margolis, Shafik Khoury, Gad Keren, and Yacov Shacham. "Prolonged Hyperglycemia and Renal Failure after Primary Percutaneous Coronary Intervention." Cardiorenal Medicine 9, no. 2 (2019): 92–99. http://dx.doi.org/10.1159/000495704.

Texte intégral

Résumé :

Background: There are limited data regarding the effect of long-standing hyperglycemia on the occurrence of acute kidney injury (AKI) in ST segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Methods: We retrospectively studied 723 STEMI patients undergoing primary PCI. Patients were stratified into two groups according to glycated hemoglobin (HbA1c) levels as a marker of prolonged hyperglycemia: those with HbA1c < 7% and those with HbA1c ≥7%. Medical records were reviewed for the occurrence of AKI. Results: HbA1c levels ≥7%

Styles APA, Harvard, Vancouver, ISO, etc.

35

Kumar, Akhilesh, and Suman Bhandari. "Management of high thrombus burden during primary percutaneous coronary intervention." Journal of Current Cardiology 2, no. 2 (2024): 85–97. http://dx.doi.org/10.4103/jcc.jcc_16_24.

Texte intégral

Résumé :

Abstract Managing high thrombus burden during primary percutaneous coronary intervention (PCI) poses significant challenges and is associated with increased procedural complications and adverse clinical outcomes. This abstract reviews current strategies and controversies surrounding the treatment of high thrombus burden in patients undergoing PCI. It discusses pharmacological approaches such as potent antiplatelet agents, glycoprotein IIb/IIIa inhibitors, and novel antithrombotic therapies, alongside mechanical strategies including thrombus aspiration and balloon angioplasty. The importance of

Styles APA, Harvard, Vancouver, ISO, etc.

36

Eltahan, mohamed. "Outcome Differences in Diabetic and Non-Diabetic Following Primary PCI In Stemi Patients." Biolife 11, no. 4 (2023): 19–26. https://doi.org/10.5281/zenodo.10273912.

Texte intégral

Résumé :

<strong>ABSTRACT</strong>The purpose of this study is to determine the outcome and associated Major Adverse Cardiac Events (successful or failed primary percutaneous coronary intervention (PCI), complicated primary PCI, heart failure, cardiac arrest, ventricular tachycardia (VT), ventricular fibrillation (VF), renal failure, shock) within six months in diabetic and non- diabetic patients presenting with ST- segment elevation myocardial infarction and treated by primary percutaneous coronary interventions. This prospective study was conducted to include one hundred and nine patients with ST-seg

Styles APA, Harvard, Vancouver, ISO, etc.

37

Dhital, Bishnu Mani, Shyam Raj Regmi, Bidhan Shrestha, Sovit Thapa, and Shahid Murtaza. "PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN COVID-19 PATEINTS." Journal of Chitwan Medical College 13, no. 1 (2023): 76–79. http://dx.doi.org/10.54530/jcmc.1207.

Texte intégral

Résumé :

Background: Coronavirus Disease 2019 is global pandemic having high morbidity and mortality. It is thought that COVID-19 can predispose high thrombus burden and lead to Acute Coronary Syndrome. The aim of this study was to compare the symptoms, angiographic characteristics and procedural outcome in COVID-19 positive and COVID-19 negative patient undergoing percutaneous coronary intervention for acute coronary syndrome. Methods: All the data of 121 patients who were admitted at Chitwan Medical College on April 2020 to September 2020, suffering from acute coronary syndrome who underwent PCI were

Styles APA, Harvard, Vancouver, ISO, etc.

38

Lu, Daniel Y., Matthew D. Saybolt, Daniel H. Kiss, et al. "One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease." Clinical Medicine Insights: Cardiology 14 (January 2020): 117954682090149. http://dx.doi.org/10.1177/1179546820901491.

Texte intégral

Résumé :

Background: Patients with cirrhosis and coronary artery disease (CAD) are at high risk for morbidity during surgical revascularization so they are often referred for complex percutaneous coronary intervention (PCI). Percutaneous coronary intervention in the cirrhotic population also has inherent risks; however, quantifiable data on long-term outcomes are lacking. Methods: Patients with angiographically significant CAD and cirrhosis were identified from the catheterization lab databases of the University of Pennsylvania Health System between 2007 and 2015. Outcomes were obtained from the medica

Styles APA, Harvard, Vancouver, ISO, etc.

39

Khan, Bahauddin, Amir Taj Khan, Afnan Muhammad, Shah Sawar, Fouzia Rahman, and Mahmood Ul Hassan. "Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusions." Pakistan Journal of Medical and Health Sciences 17, no. 2 (2023): 859–61. http://dx.doi.org/10.53350/pjmhs2023172859.

Texte intégral

Résumé :

Introduction: Percutaneous coronary intervention (PCI) is a minimally invasive procedure used to treat patients with coronary artery disease. Chronic total occlusions (CTO) occur when a coronary artery is completely blocked for more than 3 months. Objectives: The main objective of the study is to find the long-term outcomes of patients undergoing percutaneous coronary intervention (PCI) for chronic total occlusions. Material and methods: The retrospective cohort study was conducted at the Hayatabad Medical Complex in Peshawar, Pakistan from June 2019 to June 2020. The study included 384 patien

Styles APA, Harvard, Vancouver, ISO, etc.

40

Matic, Dragan, Milika Asanin, Sanja Stankovic, et al. "Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention." Vojnosanitetski pregled 72, no. 7 (2015): 589–95. http://dx.doi.org/10.2298/vsp140223064m.

Texte intégral

Résumé :

Background/Aim. Data about bleeding complicating primary percutaneous coronary intervention (PCI) are more frequently obtained from randomized clinical trials on patients with acute coronary syndromes (ACS), but less frequently from surveys or registries on patients with STelevation myocardial infarction (STEMI). The aim of this study was to investigate the incidence, predictors and prognostic impact of in-hospital major bleeding in the population of unselected real-world patients with acute STEMI undergoing primary PCI. Methods. All consecutive patients presenting with STEMI who underwent pri

Styles APA, Harvard, Vancouver, ISO, etc.

41

Ohayon, Paul, Anthony Matta, and Nicolas Boudou. "A case report of an iatrogenic coronary cameral fistula treated by retrograde percutaneous coronary intervention." European Heart Journal - Case Reports 4, no. 3 (2020): 1–6. http://dx.doi.org/10.1093/ehjcr/ytaa094.

Texte intégral

Résumé :

Abstract Background Acquired coronary cameral fistula is an extremely rare condition that involves an abnormal communication between a coronary artery and a cardiac chamber. It usually occurs after chest trauma or cardiovascular interventions, such as percutaneous coronary intervention (PCI) and is associated with various outcomes, ranging from a stable status to haemodynamic instability. Acquired coronary cameral fistula frequently arises from the right coronary artery and drains generally into the right ventricle. Case summary We report the unusual case of a 56-year-old male patient referred

Styles APA, Harvard, Vancouver, ISO, etc.

42

Kadel, Arun, Shova Karki, Binay Kumar Rauniyar, et al. "Impact of COVID 19 on outcome of primary percutaneous coronary intervention in Nepal." Nepalese Heart Journal 19, no. 2 (2022): 5–7. http://dx.doi.org/10.3126/njh.v20i2.48863.

Texte intégral

Résumé :

Background and Aims: The COVID 19 pandemic have affected the patients with ST segment elevation myocardial infarction as the number of patients presenting with STEMI declined substantially and those who underwent primary PCI had poor outcome. Our aim was to analyze the in-hospital and 30-days mortality in STEMI undergoing Primary PCI during second wave of COVID 19. Methods: A prospective cohort study was conducted at Shahid Gangalal National Heart Centre, Bansbari, Kathmandu. Convenience sampling of patients who underwent primary PCI were enrolled in this study and were followed up for 3

Styles APA, Harvard, Vancouver, ISO, etc.

43

Sajjad, Wasim, Tariq Nawaz, Hassan Ali, Muhammad Amin, and Sadam Hussain. "Outcome of Primary Percutaneous Coronary Intervention for STEMI due to Stent Thrombosis." Journal of Health and Rehabilitation Research 4, no. 1 (2024): 573–77. http://dx.doi.org/10.61919/jhrr.v4i1.477.

Texte intégral

Résumé :

Background: Stent thrombosis (ST) is a critical complication following percutaneous coronary intervention (PCI), contributing significantly to morbidity and mortality in patients with ST-elevation myocardial infarction (STEMI). Advances in drug-eluting stent technology and antiplatelet therapy have mitigated, but not eliminated, the risk of ST. The management of STEMI due to ST in resource-limited settings remains a challenging endeavor, necessitating a comprehensive evaluation of treatment outcomes. Objective: To assess the mortality rates and clinical outcomes following primary PCI in patien

Styles APA, Harvard, Vancouver, ISO, etc.

44

Ullah, Ikram, Amir Rashid Qureshi, Sami Ullah, Mohammad Asghar Khan, Muhammad Salman, and Hamid Ali Shah. "Predictors of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention." Journal of Gandhara Medical and Dental Science 10, no. 2 (2023): 67–70. http://dx.doi.org/10.37762/jgmds.10-2.379.

Texte intégral

Résumé :

OBJECTIVES To identify the speciﬁc predictors of acute stent thrombosis in patients after primary percutaneous coronary intervention.METHODOLOGY This retrospective study was carried out at the Department of Cardiology Hayatabad Medical Complex Peshawar from 1st January to 30th June 2022. All consecutive patients with an angiographically conﬁrmed stent thrombosis were enrolled. Patients gave informed consent for the inclusion of data in this registry. Stent thrombosis was categorized according to the timing of the event as acute (occurrence within the ﬁrst 24 hours after the index procedure).RE

Styles APA, Harvard, Vancouver, ISO, etc.

45

Crouch, Michael A., Jean M. Nappi, and Kai I. Cheang. "Glycoprotein IIb/IIIa Receptor Inhibitors in Percutaneous Coronary Intervention and Acute Coronary Syndrome." Annals of Pharmacotherapy 37, no. 6 (2003): 860–75. http://dx.doi.org/10.1345/aph.1c338.

Texte intégral

Résumé :

OBJECTIVE: To review the contemporary role of the glycoprotein (GYP) IIb/IIIa receptor inhibitors abciximab, eptifibatide, and tirofiban in patients undergoing percutaneous coronary intervention (PCI) and those with an acute coronary syndrome (ACS), and to provide an algorithm based on currently available evidence for specific agents. DATA SOURCES: Primary articles were identified by a MEDLINE search (1966–January 2003); references cited in these articles provided additional resources. STUDY SELECTION AND DATA EXTRACTION: All of the articles identified from data sources were considered for rel

Styles APA, Harvard, Vancouver, ISO, etc.

46

Milašinović, Dejan. "Association between coronary microvascular dysfunction indices and infarction size following primary percutaneous coronary intervention." Medicinska istrazivanja 58, no. 2 (2025): 109–16. https://doi.org/10.5937/medi58-55877.

Texte intégral

Résumé :

Introduction: Coronary microvascular dysfunction (CMD) has been associated with impaired prognosis in patients with ST-elevation myocardial infarction (STEMI) despite timely and successful primary percutaneous coronary intervention (PCI). Our aim was to compare the ability of two different CMD indices, coronary flow reserve (CFR) and hyperemic microvascular resistance (HMR), to predict infarct size. Methods: The analysis included 31 patients with STEMI in whom valid invasive measurements of coronary blood flow velocity with the Doppler-tipped coronary wire had been performed at the end of prim

Styles APA, Harvard, Vancouver, ISO, etc.

47

McCallum, Craig J., Katy Stewart, and Paul D. MacIntyre. "The illness perceptions of patients with percutaneous coronary intervention compared to patients with no percutaneous intervention, for acute myocardial infarction, in cardiac rehabilitation." Coronary Artery Disease 34, no. 7 (2023): 496–503. http://dx.doi.org/10.1097/mca.0000000000001267.

Texte intégral

Résumé :

Purpose Patients who receive percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) have been found to have low attendance at cardiac rehabilitation (CR). It has been suggested that this is because PCI patients have a benign perception of their coronary disease; however, this has never been quantitatively investigated. The aim of this prospective study was to evaluate the illness perceptions (IP) of patients with AMI treated with PCI. Methods The Heart Health Illness Perception Questionnaire (modified version of the Brief Illness Perception Questionnaire) and the Cardia

Styles APA, Harvard, Vancouver, ISO, etc.

48

Zheleva-Kyuchukova, I., and V. Gelev. "Immediate outcome after percutaneous coronary mmediate outcome after percutaneous coronary revascularization in stemi for left main coronary artery lesion evascularization in stemi for left main coronary artery lesions." Bulgarian Cardiology 29, no. (1) (2023): 76–85. https://doi.org/10.3897/bgcardio.29.e100555.

Texte intégral

Résumé :

<strong>Background:</strong> Acute coronary syndrome with ST elevation (STEMI) with a lesion in the left main coronary artery (LMCA) occurs infrequently; moreover, patients are at very high risk for mortality. However, limited data are available regarding the prevalence, clinical characteristics, and outcomes of patients presenting with LM-STEMI treated with percutaneous coronary intervention (LM-PCI STEMI). Therefore, we aimed to evaluate patient clinical and procedure factors associated with in-hospital outcomes in LM-STEMI patients undergoing PPCI in a real-life registry. <strong>Material a

Styles APA, Harvard, Vancouver, ISO, etc.

49

Jamwal, Naveen, and Shiv Shanker Tripathi. "Prasugrel versus ticagrelor in patients with Acute Coronary syndrome treated with percutaneous coronary intervention." International Journal of Research in Medical Sciences 6, no. 6 (2018): 1945. http://dx.doi.org/10.18203/2320-6012.ijrms20182052.

Texte intégral

Résumé :

Background: No association studies for the efficacy and safety of ticagrelor vs. prasugrel have been published in India. Aim of the study was to compare the safety and efficacy of Prasugrel versus Ticagrelor in Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.Methods: This retrospective study was designed to compare the efficacy and safety of prasugrel and ticagrelor in acute coronary syndromes (ACS) with percutaneous coronary intervention (PCI). A total of 480 patients were studied who had been prescribed either prasugrel or ticagrelor during PCI. Primary

Styles APA, Harvard, Vancouver, ISO, etc.

50

Hamed, Abd Rabou, Ahmed Elkersh, Ahmed Hegab, and Abdulaziz Aboshahba. "Effect of Coronary Arterial Dominance Post Primary Percutaneous Coronary Artery Intervention (PCI) during Hospital Stay and at 3-Month Follow-up." Clinical Cardiology and Cardiovascular Interventions 5, no. 4 (2022): 01–05. http://dx.doi.org/10.31579/2641-0419/246.

Texte intégral

Résumé :

Background: Coronary vessel dominance, defined by the coronary artery that supplies the posterior descending artery (PDA) and posterolateral branches, influences the relative contribution of the different coronary arteries to the total left ventricular blood flow. This work aimed to evaluate the prognostic value of coronary arterial dominance post primary PCI, during hospital stay and at 3-month follow-up, which include; cardiac mortality, heart failure, non-fatal myocardial infarction, re-vascularization, stroke/TIA and re-admission for ACS. Methods: This prospective observational study inclu

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!